188 related articles for article (PubMed ID: 34718043)
1. Hematopoietic cell transplantation in severe combined immunodeficiency: The SCETIDE 2006-2014 European cohort.
Lankester AC; Neven B; Mahlaoui N; von Asmuth EGJ; Courteille V; Alligon M; Albert MH; Serra IB; Bader P; Balashov D; Beier R; Bertrand Y; Blanche S; Bordon V; Bredius RG; Cant A; Cavazzana M; Diaz-de-Heredia C; Dogu F; Ehlert K; Entz-Werle N; Fasth A; Ferrua F; Ferster A; Formankova R; Friedrich W; Gonzalez-Vicent M; Gozdzik J; Güngör T; Hoenig M; Ikinciogullari A; Kalwak K; Kansoy S; Kupesiz A; Lanfranchi A; Lindemans CA; Meisel R; Michel G; Miranda NAA; Moraleda J; Moshous D; Pichler H; Rao K; Sedlacek P; Slatter M; Soncini E; Speckmann C; Sundin M; Toren A; Vettenranta K; Worth A; Yeşilipek MA; Zecca M; Porta F; Schulz A; Veys P; Fischer A; Gennery AR
J Allergy Clin Immunol; 2022 May; 149(5):1744-1754.e8. PubMed ID: 34718043
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic Cell Transplantation for Adenosine Deaminase Severe Combined Immunodeficiency-Improved Outcomes in the Modern Era.
Ghimenton E; Flinn A; Lum SH; Leahy TR; Nademi Z; Owens S; Williams E; Flood T; Hambleton S; Slatter M; Gennery AR
J Clin Immunol; 2022 May; 42(4):819-826. PubMed ID: 35288820
[TBL] [Abstract][Full Text] [Related]
3. Clinical and Laboratory Factors Affecting the Prognosis of Severe Combined Immunodeficiency.
Ozturk E; Catak MC; Kiykim A; Baser D; Bilgic Eltan S; Yalcin K; Kasap N; Nain E; Bulutoglu A; Akgun G; Can Y; Sefer AP; Babayeva R; Caki-Kilic S; Tezcan Karasu G; Yesilipek A; Ozen A; Karakoc-Aydiner E; Baris S
J Clin Immunol; 2022 Jul; 42(5):1036-1050. PubMed ID: 35451701
[TBL] [Abstract][Full Text] [Related]
4. B-cell differentiation and IL-21 response in
Miggelbrink AM; Logan BR; Buckley RH; Parrott RE; Dvorak CC; Kapoor N; Abdel-Azim H; Prockop SE; Shyr D; Decaluwe H; Hanson IC; Gillio A; Dávila Saldaña BJ; Eibel H; Hopkins G; Walter JE; Whangbo JS; Kohn DB; Puck JM; Cowan MJ; Griffith LM; Haddad E; O'Reilly RJ; Notarangelo LD; Pai SY
Blood; 2018 Jun; 131(26):2967-2977. PubMed ID: 29728406
[TBL] [Abstract][Full Text] [Related]
5. Matched versus Haploidentical Hematopoietic Stem Cell Transplantation as Treatment Options for Primary Immunodeficiencies in Children.
Holzer U; Döring M; Eichholz T; Ebinger M; Queudeville M; Turkiewicz D; Schwarz K; Handgretinger R; Lang P; Toporski J
Transplant Cell Ther; 2021 Jan; 27(1):71.e1-71.e12. PubMed ID: 32966882
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic stem cell transplantation for CD40 ligand deficiency: Results from an EBMT/ESID-IEWP-SCETIDE-PIDTC study.
Ferrua F; Galimberti S; Courteille V; Slatter MA; Booth C; Moshous D; Neven B; Blanche S; Cavazzana M; Laberko A; Shcherbina A; Balashov D; Soncini E; Porta F; Al-Mousa H; Al-Saud B; Al-Dhekri H; Arnaout R; Formankova R; Bertrand Y; Lange A; Smart J; Wolska-Kusnierz B; Aquino VM; Dvorak CC; Fasth A; Fouyssac F; Heilmann C; Hoenig M; Schuetz C; Kelečić J; Bredius RGM; Lankester AC; Lindemans CA; Suarez F; Sullivan KE; Albert MH; Kałwak K; Barlogis V; Bhatia M; Bordon V; Czogala W; Alonso L; Dogu F; Gozdzik J; Ikinciogullari A; Kriván G; Ljungman P; Meyts I; Mustillo P; Smith AR; Speckmann C; Sundin M; Keogh SJ; Shaw PJ; Boelens JJ; Schulz AS; Sedlacek P; Veys P; Mahlaoui N; Janda A; Davies EG; Fischer A; Cowan MJ; Gennery AR;
J Allergy Clin Immunol; 2019 Jun; 143(6):2238-2253. PubMed ID: 30660643
[TBL] [Abstract][Full Text] [Related]
7. Single-Center Experience of Unrelated and Haploidentical Stem Cell Transplantation with TCRαβ and CD19 Depletion in Children with Primary Immunodeficiency Syndromes.
Balashov D; Shcherbina A; Maschan M; Trakhtman P; Skvortsova Y; Shelikhova L; Laberko A; Livshits A; Novichkova G; Maschan A
Biol Blood Marrow Transplant; 2015 Nov; 21(11):1955-62. PubMed ID: 26187864
[TBL] [Abstract][Full Text] [Related]
8. Reticular dysgenesis: international survey on clinical presentation, transplantation, and outcome.
Hoenig M; Lagresle-Peyrou C; Pannicke U; Notarangelo LD; Porta F; Gennery AR; Slatter M; Cowan MJ; Stepensky P; Al-Mousa H; Al-Zahrani D; Pai SY; Al Herz W; Gaspar HB; Veys P; Oshima K; Imai K; Yabe H; Noroski LM; Wulffraat NM; Sykora KW; Soler-Palacin P; Muramatsu H; Al Hilali M; Moshous D; Debatin KM; Schuetz C; Jacobsen EM; Schulz AS; Schwarz K; Fischer A; Friedrich W; Cavazzana M;
Blood; 2017 May; 129(21):2928-2938. PubMed ID: 28331055
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic stem cell transplantation for severe combined immunodeficiency diseases.
Cowan MJ; Neven B; Cavazanna-Calvo M; Fischer A; Puck J
Biol Blood Marrow Transplant; 2008 Jan; 14(1 Suppl 1):73-5. PubMed ID: 18162224
[TBL] [Abstract][Full Text] [Related]
10. Clinical Features and HSCT Outcome for SCID in Turkey.
Ikinciogullari A; Cagdas D; Dogu F; Tugrul T; Karasu G; Haskologlu S; Aksoylar S; Uygun V; Kupesiz A; Yildiran A; Gursel O; Ates C; Elhan A; Kansoy S; Yesilipek A; Tezcan I;
J Clin Immunol; 2019 Apr; 39(3):316-323. PubMed ID: 30924026
[TBL] [Abstract][Full Text] [Related]
11. Who Is a Better Donor for Recipients of Allogeneic Hematopoietic Cell Transplantation: A Young HLA-Mismatched Haploidentical Relative or an Older Fully HLA-Matched Sibling or Unrelated Donor?
Karam E; Laporte J; Solomon SR; Morris LE; Zhang X; Holland HK; Bashey A; Solh MM
Biol Blood Marrow Transplant; 2019 Oct; 25(10):2054-2060. PubMed ID: 31173900
[TBL] [Abstract][Full Text] [Related]
12. Comparable outcomes among unmanipulated haploidentical, matched unrelated, and matched sibling donors in BU-based myeloablative hematopoietic stem cell transplantation for intermediate and adverse risk acute myeloid leukemia in complete remission: a single-center study.
Lu Y; Zhao YL; Zhang JP; Xiong M; Cao XY; Liu DY; Sun RJ; Wei ZJ; Zhou JR; Lu DP
Ann Hematol; 2021 Jun; 100(6):1579-1591. PubMed ID: 33236196
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Immune Recovery After Hematopoietic Stem Cell Transplantation for ADA Deficiency: a Single-Center Experience.
Kreins AY; Velasco HF; Cheong KN; Rao K; Veys P; Worth A; Gaspar HB; Booth C
J Clin Immunol; 2022 Jan; 42(1):94-107. PubMed ID: 34654999
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic Stem Cell Transplantation from HLA-Mismatched Donors for Pediatric Patients with Acute Lymphoblastic Leukemia Treated According to the 2003 BFM and 2007 International BFM Studies: Impact of Disease Risk on Outcomes.
Dalle JH; Balduzzi A; Bader P; Lankester A; Yaniv I; Wachowiak J; Pieczonka A; Bierings M; Yesilipek A; Sedlaçek P; Ifversen M; Sufliarska S; Toporski J; Glogova E; Poetschger U; Peters C
Biol Blood Marrow Transplant; 2018 Sep; 24(9):1848-1855. PubMed ID: 29772352
[TBL] [Abstract][Full Text] [Related]
15. Immune Reconstitution and Infection Patterns after Early Alemtuzumab and Reduced Intensity Transplantation for Nonmalignant Disorders in Pediatric Patients.
Bhatt ST; Bednarski JJ; Berg J; Trinkaus K; Murray L; Hayashi R; Schulz G; Hente M; Grimley M; Chan KW; Kamani N; Jacobsohn D; Nieder M; Hale G; Yu L; Adams R; Dalal J; Pulsipher MA; Haut P; Chaudhury S; Davis J; Jaroscak J; Andreansky M; Willert J; Shenoy S
Biol Blood Marrow Transplant; 2019 Mar; 25(3):556-561. PubMed ID: 30321596
[TBL] [Abstract][Full Text] [Related]
16. Multicenter Outcome of Hematopoietic Stem Cell Transplantation for Primary Immune Deficiency Disorders in India.
Raj R; Aboobacker FN; Yadav SP; Uppuluri R; Bhat S; Choudhry D; Dua V; Kharya G; Rastogi N; Sachdev M; Khandelwal V; Swaminathan V; Bakane A; Ramakrishnan B; George B
Front Immunol; 2020; 11():606930. PubMed ID: 33488609
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic stem cell transplantation for CD3δ deficiency.
Marcus N; Takada H; Law J; Cowan MJ; Gil J; Regueiro JR; Plaza Lopez de Sabando D; Lopez-Granados E; Dalal J; Friedrich W; Manfred H; Hanson IC; Grunebaum E; Shearer WT; Roifman CM
J Allergy Clin Immunol; 2011 Nov; 128(5):1050-7. PubMed ID: 21757226
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of patients with severe combined immunodeficiency treated with hematopoietic stem cell transplantation with and without preconditioning.
Patel NC; Chinen J; Rosenblatt HM; Hanson IC; Krance RA; Paul ME; Abramson SL; Noroski LM; Davis CM; Seeborg FO; Foster SB; Leung KS; Brown BS; Ritz J; Shearer WT
J Allergy Clin Immunol; 2009 Nov; 124(5):1062-9.e1-4. PubMed ID: 19895994
[TBL] [Abstract][Full Text] [Related]
19. SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery.
Haddad E; Logan BR; Griffith LM; Buckley RH; Parrott RE; Prockop SE; Small TN; Chaisson J; Dvorak CC; Murnane M; Kapoor N; Abdel-Azim H; Hanson IC; Martinez C; Bleesing JJH; Chandra S; Smith AR; Cavanaugh ME; Jyonouchi S; Sullivan KE; Burroughs L; Skoda-Smith S; Haight AE; Tumlin AG; Quigg TC; Taylor C; Dávila Saldaña BJ; Keller MD; Seroogy CM; Desantes KB; Petrovic A; Leiding JW; Shyr DC; Decaluwe H; Teira P; Gillio AP; Knutsen AP; Moore TB; Kletzel M; Craddock JA; Aquino V; Davis JH; Yu LC; Cuvelier GDE; Bednarski JJ; Goldman FD; Kang EM; Shereck E; Porteus MH; Connelly JA; Fleisher TA; Malech HL; Shearer WT; Szabolcs P; Thakar MS; Vander Lugt MT; Heimall J; Yin Z; Pulsipher MA; Pai SY; Kohn DB; Puck JM; Cowan MJ; O'Reilly RJ; Notarangelo LD
Blood; 2018 Oct; 132(17):1737-1749. PubMed ID: 30154114
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of hematopoietic stem cell transplantation for IL2RG/JAK3 SCID: a cohort report.
Abd Hamid IJ; Slatter MA; McKendrick F; Pearce MS; Gennery AR
Blood; 2017 Apr; 129(15):2198-2201. PubMed ID: 28209722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
